AbCellera Biologics Inc vs Aspen Aerogels Inc — how do they compare? AbCellera Biologics Inc trades at $9.07 (market cap $2.99B), while Aspen Aerogels Inc trades at $6.15 (market cap $509.55M). The key difference: AbCellera Biologics Inc is far larger — about 5.9× Aspen Aerogels Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Aspen Aerogels Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | ASPN | |
|---|---|---|
Market Cap | $2.99B | $509.55M |
Sector | Health | Technology |
52-Week High | $9.76 | $8.82 |
52-Week Low | $2.78 | $2.57 |
Enterprise Value | $2.58B | $482.96M |
Trailing returns across standard periods
Latest headlines on both assets
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →Aspen Aerogels is an aerogel technology company that designs high-performance insulation. Its products are used in energy infrastructure and electric vehicles to provide thermal management and fire protection.
Read more on ASPN →